305 related articles for article (PubMed ID: 34482632)
1. Role of the MOZ/MLL-mediated transcriptional activation system for self-renewal in normal hematopoiesis and leukemogenesis.
Yokoyama A
FEBS J; 2022 Dec; 289(24):7987-8002. PubMed ID: 34482632
[TBL] [Abstract][Full Text] [Related]
2. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
Yokoyama A
Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
[TBL] [Abstract][Full Text] [Related]
3. Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.
Miyamoto R; Okuda H; Kanai A; Takahashi S; Kawamura T; Matsui H; Kitamura T; Kitabayashi I; Inaba T; Yokoyama A
Cell Rep; 2020 Sep; 32(13):108200. PubMed ID: 32997997
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.
Paggetti J; Largeot A; Aucagne R; Jacquel A; Lagrange B; Yang XJ; Solary E; Bastie JN; Delva L
Oncogene; 2010 Sep; 29(36):5019-31. PubMed ID: 20581860
[TBL] [Abstract][Full Text] [Related]
5. [The mechanism of MLL-rearranged leukemogenesis and its targeted therapies].
Yokoyama A
Rinsho Ketsueki; 2021; 62(8):988-997. PubMed ID: 34497239
[TBL] [Abstract][Full Text] [Related]
6. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
Katsumoto T; Yoshida N; Kitabayashi I
Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
[TBL] [Abstract][Full Text] [Related]
7. Symplekin, a polyadenylation factor, prevents MOZ and MLL activity on HOXA9 in hematopoietic cells.
Largeot A; Paggetti J; Broséus J; Aucagne R; Lagrange B; Martin RZ; Berthelet J; Quéré R; Lucchi G; Ducoroy P; Bastie JN; Delva L
Biochim Biophys Acta; 2013 Dec; 1833(12):3054-3063. PubMed ID: 23994619
[TBL] [Abstract][Full Text] [Related]
8. MOZ is essential for maintenance of hematopoietic stem cells.
Katsumoto T; Aikawa Y; Iwama A; Ueda S; Ichikawa H; Ochiya T; Kitabayashi I
Genes Dev; 2006 May; 20(10):1321-30. PubMed ID: 16702405
[TBL] [Abstract][Full Text] [Related]
9. MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
Katsumoto T; Ogawara Y; Yamagata K; Aikawa Y; Goitsuka R; Nakamura T; Kitabayashi I
Blood Adv; 2022 Oct; 6(19):5527-5537. PubMed ID: 35947126
[TBL] [Abstract][Full Text] [Related]
10. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
Elife; 2021 Aug; 10():. PubMed ID: 34431785
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of MLL-associated leukemia.
Yokoyama A
Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
[TBL] [Abstract][Full Text] [Related]
12. MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain.
Becht DC; Klein BJ; Kanai A; Jang SM; Cox KL; Zhou BR; Phanor SK; Zhang Y; Chen RW; Ebmeier CC; Lachance C; Galloy M; Fradet-Turcotte A; Bulyk ML; Bai Y; Poirier MG; Côté J; Yokoyama A; Kutateladze TG
Nat Commun; 2023 Feb; 14(1):697. PubMed ID: 36754959
[TBL] [Abstract][Full Text] [Related]
13. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.
Yang XJ; Ullah M
Oncogene; 2007 Aug; 26(37):5408-19. PubMed ID: 17694082
[TBL] [Abstract][Full Text] [Related]
14. The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
Perez-Campo FM; Borrow J; Kouskoff V; Lacaud G
Blood; 2009 May; 113(20):4866-74. PubMed ID: 19264921
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation by MLL fusion proteins in leukemogenesis.
Yokoyama A
Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
[TBL] [Abstract][Full Text] [Related]
16. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
[TBL] [Abstract][Full Text] [Related]
17. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
18. The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis.
Perez-Campo FM; Costa G; Lie-a-Ling M; Kouskoff V; Lacaud G
Immunology; 2013 Jun; 139(2):161-5. PubMed ID: 23347099
[TBL] [Abstract][Full Text] [Related]
19. Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.
Ullah M; Pelletier N; Xiao L; Zhao SP; Wang K; Degerny C; Tahmasebi S; Cayrou C; Doyon Y; Goh SL; Champagne N; Côté J; Yang XJ
Mol Cell Biol; 2008 Nov; 28(22):6828-43. PubMed ID: 18794358
[TBL] [Abstract][Full Text] [Related]
20. MOZ and BMI1 act synergistically to maintain hematopoietic stem cells.
Sheikh BN; Metcalf D; Voss AK; Thomas T
Exp Hematol; 2017 Mar; 47():83-97.e8. PubMed ID: 27773671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]